Cue Health Inc. (HLTH) Tops Q2 EPS by 9c

Cue Health Inc. (NASDAQ: HLTH) reported Q2 EPS of ($0.37), $0.09 better than the analyst estimate of ($0.46). Revenue for the quarter came in at $87.7 million versus the consensus estimate of $52.91 million.

For earnings history and earnings-related data on Cue Health Inc. (HLTH) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M